What Capricor Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 13 |
| Total trades | 0 | 32 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 284,966 |
| Disposed | 0 | 272,529 |
| Net activity | +0 | +12,437 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Krasney Karen | EVP, GENERAL COUNSEL | Jun 25 | Open-market sale · S | −24,100 | $30.38 | −$732K | 30,547 |
| Krasney Karen | EVP, GENERAL COUNSEL | Jun 25 | Exercise / conversion · M | +24,100 | $3.18 | +$76.6K | 54,647 |
| Bergmann Anthony | CHIEF FINANCIAL OFFICER | Jun 25 | Open-market sale · S | −24,100 | $30.38 | −$732K | 11,223 |
| Bergmann Anthony | CHIEF FINANCIAL OFFICER | Jun 25 | Exercise / conversion · M | +24,100 | $3.18 | +$76.6K | 35,323 |
| Bergmann Anthony | CHIEF FINANCIAL OFFICER | Jun 24 | Open-market sale · S | −400 | $30.00 | −$12K | 11,223 |
| Bergmann Anthony | CHIEF FINANCIAL OFFICER | Jun 24 | Exercise / conversion · M | +400 | $3.18 | +$1.27K | 11,623 |
| Krasney Karen | EVP, GENERAL COUNSEL | Jun 24 | Open-market sale · S | −400 | $30.00 | −$12K | 30,547 |
| Krasney Karen | EVP, GENERAL COUNSEL | Jun 24 | Exercise / conversion · M | +400 | $3.18 | +$1.27K | 30,947 |
| Bergmann Anthony | CHIEF FINANCIAL OFFICER | Jun 22 | Open-market sale · S | −500 | $30.00 | −$15K | 11,223 |
| Bergmann Anthony | CHIEF FINANCIAL OFFICER | Jun 22 | Exercise / conversion · M | +500 | $3.18 | +$1.59K | 11,723 |
| Krasney Karen | EVP, GENERAL COUNSEL | Jun 22 | Open-market sale · S | −500 | $30.00 | −$15K | 30,547 |
| Krasney Karen | EVP, GENERAL COUNSEL | Jun 22 | Exercise / conversion · M | +500 | $3.18 | +$1.59K | 31,047 |
| Bergmann Anthony | CHIEF FINANCIAL OFFICER | May 18 | Exercise / conversion · M | +3,000 | $1.39 | +$4.17K | 11,223 |
| Litvack Frank | Director | May 13 | Exercise / conversion · M | +3,937 | $1.39 | +$5.47K | 133,776 |
| Bergmann Anthony | CHIEF FINANCIAL OFFICER | May 01 | Open-market sale · S | −25,000 | $31.70 | −$793K | 8,223 |
| Bergmann Anthony | CHIEF FINANCIAL OFFICER | May 01 | Exercise / conversion · M | +25,000 | $3.18 | +$79.5K | 33,223 |
| Krasney Karen | EVP, GENERAL COUNSEL | May 01 | Open-market sale · S | −25,000 | $31.70 | −$793K | 30,547 |
| Krasney Karen | EVP, GENERAL COUNSEL | May 01 | Exercise / conversion · M | +25,000 | $3.18 | +$79.5K | 55,547 |
| Sabar Karimah Es | Director | Apr 02 | Open-market sale · S | −7,529 | $32.00 | −$241K | 0 |
| Sabar Karimah Es | Director | Apr 02 | Exercise / conversion · M | +7,529 | $3.18 | +$23.9K | 7,529 |
Loading...
